Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | |||
| Cardiac arrest | postmarketing | x | x | ||||||
| Cardiac disorder | postmarketing | x | x | ||||||
| Hepatic failure | postmarketing | x | x | x | |||||
| Hepatic necrosis | postmarketing | x | x | x | |||||
| Hepatobiliary disease | postmarketing | x | |||||||
| Arrhythmia | x | x | x | x | x | x | |||
| Bronchospasm | x | ||||||||
| Cough | x | x | |||||||
| Delirium | x | x | |||||||
| Rash | x | ||||||||
| Body temperature increased | x | x | x | x | x | ||||
| Hallucination | x | x | |||||||
| Hepatitis | x | x | x | ||||||
| Hiccups | x | x | |||||||
| Hypercapnia | x | ||||||||
| Hyperglycaemia | x | ||||||||
| Hyperkalaemia | x | x | x | ||||||
| Hypotension | x | x | x | x | x | x | x | ||
| Jaundice | x | x | x | ||||||
| Laryngospasm | x | x | |||||||
| Muscle rigidity | x | ||||||||
| Nausea | x | x | x | x | x | x | x | ||
| Necrosis | x | ||||||||
| Salivation | x | ||||||||
| Shivering | x | x | x | x | x | x | x | ||
| Vomiting | x | x | x | x | x | x | x | ||
| Hepatic function abnormal | x | x | x | x | |||||
| Hepatocellular injury | x | ||||||||
| Liver injury | x | ||||||||
| Excitement | x | ||||||||
| Respiratory depression | x | x | x | x | x | x | x | ||
| Breath holding | x | ||||||||
| Postoperative ileus | x | x | |||||||
| Breath holding attack | x | ||||||||
| Rhythm idioventricular | x | ||||||||
| Ileus | x | x | x | ||||||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Diabetic | x | ||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |